Acute respiratory distress syndrome (ARDS) is characterised by acute hypoxaemic
respiratory failure with bilateral infiltrates on chest imaging, which is not fully explained by …

The acute course of COVID-19 is variable and ranges from asymptomatic infection to
fulminant respiratory failure. Patients recovering from COVID-19 can have persistent …

COVID-19 pandemic is a serious concern in the new era. Acute respiratory distress
syndrome (ARDS), and lung failure are the main lung diseases in COVID-19 patients. Even …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral RNA
(vRNA) is detected in the bloodstream of some patients with coronavirus disease 2019 …

The association of respiratory mechanics, particularly respiratory system static compliance
(C RS), with severity of hypoxaemia in patients with COVID-19-related acute respiratory …

Acute respiratory distress syndrome (ARDS) is a serious complication of COVID-19. This
study aimed to evaluate the prevalence of ARDS among patients hospitalized with COVID …

Acute respiratory distress syndrome (ARDS) is a heterogeneous syndrome historically
characterized by the presence of severe hypoxemia, high-permeability pulmonary edema …

Critically ill patients manifest many of the same immune features seen in coronavirus
disease 2019 (COVID-19), including both “cytokine storm” and “immune suppression.” …

The SARS-CoV-2 pandemic has not only caused millions of deaths but left also millions of
people with persistent symptoms behind. These long-term COVID-19 sequelae cause a …

The worldwide pandemic caused by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has infected an estimated 200 million people with over 4 million deaths …